147 related articles for article (PubMed ID: 24687953)
1. Evaluation of the HerpeSelect Express rapid test in the detection of herpes simplex virus type 2 antibodies in patients with genital ulcer disease.
Al-Shobaili H; Hassanein KM; Mostafa MS; Al Duways AS
J Clin Lab Anal; 2015 Jan; 29(1):43-6. PubMed ID: 24687953
[TBL] [Abstract][Full Text] [Related]
2. Performance of HerpeSelect and Kalon assays in detection of antibodies to herpes simplex virus type 2.
LeGoff J; Mayaud P; Gresenguet G; Weiss HA; Nzambi K; Frost E; Pepin J; Belec L;
J Clin Microbiol; 2008 Jun; 46(6):1914-8. PubMed ID: 18385443
[TBL] [Abstract][Full Text] [Related]
3. Herpes simplex virus type 2 antibody detection performance in Kisumu, Kenya, using the Herpeselect ELISA, Kalon ELISA, Western blot and inhibition testing.
Smith JS; Bailey RC; Westreich DJ; Maclean I; Agot K; Ndinya-Achola JO; Hogrefe W; Morrow RA; Moses S
Sex Transm Infect; 2009 Apr; 85(2):92-6. PubMed ID: 18955387
[TBL] [Abstract][Full Text] [Related]
4. Performance of the HerpeSelect (Focus) and Kalon enzyme-linked immunosorbent assays for detection of antibodies against herpes simplex virus type 2 by use of monoclonal antibody-blocking enzyme immunoassay and clinicovirological reference standards in Brazil.
Nascimento MC; Ferreira S; Sabino E; Hamilton I; Parry J; Pannuti CS; Mayaud P
J Clin Microbiol; 2007 Jul; 45(7):2309-11. PubMed ID: 17507516
[TBL] [Abstract][Full Text] [Related]
5. Time course of seroconversion by HerpeSelect ELISA after acquisition of genital herpes simplex virus type 1 (HSV-1) or HSV-2.
Ashley-Morrow R; Krantz E; Wald A
Sex Transm Dis; 2003 Apr; 30(4):310-4. PubMed ID: 12671550
[TBL] [Abstract][Full Text] [Related]
6. Comparison of focus HerpesSelect and Kalon HSV-2 gG2 ELISA serological assays to detect herpes simplex virus type 2 antibodies in a South African population.
Delany-Moretlwe S; Jentsch U; Weiss H; Moyes J; Ashley-Morrow R; Stevens W; Mayaud P
Sex Transm Infect; 2010 Feb; 86(1):46-50. PubMed ID: 19837726
[TBL] [Abstract][Full Text] [Related]
7. Rapid, sensitive, and specific lateral-flow immunochromatographic point-of-care device for detection of herpes simplex virus type 2-specific immunoglobulin G antibodies in serum and whole blood.
Laderman EI; Whitworth E; Dumaual E; Jones M; Hudak A; Hogrefe W; Carney J; Groen J
Clin Vaccine Immunol; 2008 Jan; 15(1):159-63. PubMed ID: 18003814
[TBL] [Abstract][Full Text] [Related]
8. Serologic detection of herpes simplex virus type 2 antibodies among pregnant women using a point-of-care test from Focus Diagnostics.
Leyland B; Kennedy MR; Wimberly YH; Levine BJ; Cherpes TL
J Clin Virol; 2009 Feb; 44(2):125-8. PubMed ID: 19131273
[TBL] [Abstract][Full Text] [Related]
9. False-negative type-specific glycoprotein G antibody responses in STI clinic patients with recurrent HSV-1 or HSV-2 DNA positive genital herpes, The Netherlands.
van Rooijen MS; Roest W; Hansen G; Kwa D; de Vries HJ
Sex Transm Infect; 2016 Jun; 92(4):257-60. PubMed ID: 26755775
[TBL] [Abstract][Full Text] [Related]
10. Performance of the Focus HerpeSelect-2 enzyme immunoassay for the detection of herpes simplex virus type 2 antibodies in seven African countries.
Mujugira A; Morrow RA; Celum C; Lingappa J; Delany-Moretlwe S; Fife KH; Heffron R; De Bruyn G; Homawoo B; Karita E; Mugo N; Vwalika B; Baeten JM;
Sex Transm Infect; 2011 Apr; 87(3):238-41. PubMed ID: 21307152
[TBL] [Abstract][Full Text] [Related]
11. Use of "biokit HSV-2 Rapid Assay" to improve the positive predictive value of Focus HerpeSelect HSV-2 ELISA.
Morrow RA; Friedrich D; Meier A; Corey L
BMC Infect Dis; 2005 Oct; 5():84. PubMed ID: 16225691
[TBL] [Abstract][Full Text] [Related]
12. Performance of commercial herpes simplex virus type-2 antibody tests using serum samples from Sub-Saharan Africa: a systematic review and meta-analysis.
Biraro S; Mayaud P; Morrow RA; Grosskurth H; Weiss HA
Sex Transm Dis; 2011 Feb; 38(2):140-7. PubMed ID: 20706175
[TBL] [Abstract][Full Text] [Related]
13. Performance of a novel test for IgM and IgG antibodies in subjects with culture-documented genital herpes simplex virus-1 or -2 infection.
Morrow R; Friedrich D
Clin Microbiol Infect; 2006 May; 12(5):463-9. PubMed ID: 16643524
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Serum Samples With Discordant Results in 2 Herpes Simplex Virus Type 2 IgG Assays.
Prince HE; Batterman HJ; Marlowe EM
Sex Transm Dis; 2022 May; 49(5):353-359. PubMed ID: 35067597
[TBL] [Abstract][Full Text] [Related]
15. Serologic screening for herpes simplex virus type 2 in persons with human immunodeficiency virus.
Van Wagoner NJ; Morrow R; Lee J; Dixon P; Hook EW
Am J Med Sci; 2013 Aug; 346(2):108-12. PubMed ID: 23154653
[TBL] [Abstract][Full Text] [Related]
16. Performance of HSV-2 type specific serological tests in men in Kenya.
Ng'ayo MO; Friedrich D; Holmes KK; Bukusi E; Morrow RA
J Virol Methods; 2010 Feb; 163(2):276-81. PubMed ID: 19854222
[TBL] [Abstract][Full Text] [Related]
17. Clinical correlates of index values in the focus HerpeSelect ELISA for antibodies to herpes simplex virus type 2 (HSV-2).
Ashley Morrow R; Krantz E; Friedrich D; Wald A
J Clin Virol; 2006 Jun; 36(2):141-5. PubMed ID: 16677855
[TBL] [Abstract][Full Text] [Related]
18. Improved performance of enzyme-linked immunosorbent assays and the effect of human immunodeficiency virus coinfection on the serologic detection of herpes simplex virus type 2 in Rakai, Uganda.
Gamiel JL; Tobian AA; Laeyendecker OB; Reynolds SJ; Morrow RA; Serwadda D; Gray RH; Quinn TC
Clin Vaccine Immunol; 2008 May; 15(5):888-90. PubMed ID: 18321879
[TBL] [Abstract][Full Text] [Related]
19. Development and use of a type-specific antibody avidity test based on herpes simplex virus type 2 glycoprotein G.
Morrow RA; Friedrich D; Krantz E; Wald A
Sex Transm Dis; 2004 Aug; 31(8):508-15. PubMed ID: 15273585
[TBL] [Abstract][Full Text] [Related]
20. Performance of four diagnostic assays for detecting herpes simplex virus type 2 antibodies in the Middle East and North Africa.
Nasrallah GK; Dargham SR; Sahara AS; Elsidiq MS; Abu-Raddad LJ
J Clin Virol; 2019 Feb; 111():33-38. PubMed ID: 30639845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
